Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03528512 · ClinicalTrials.gov registry record · Phase 4
IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair
A Phase 4 study, sponsored by Corewell Health East.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT03528512 is a Phase 4 study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 5 participants.
The verdict
NCT03528512, a Phase 4 study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
Often, repair of the cuts (laceration repair) proves to be traumatic for the children and the parents. Nasal spray (Intranasal/IN) approaches for procedural pain reduction, such as during dental work, have been demonstrated to make drug administration painless and well tolerated. We are comparing IN ketamine to IN midazolam and fentanyl for pain and reducing anxiety during repair of cuts in children.
Interventions
- DRUG Ketamine
- DRUG Midazolam and fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2019-02-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03528512
The ClinicalTrials.gov registry entry for NCT03528512 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT03528512 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03528512 about?
NCT03528512 is a clinical study titled "IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair". Often, repair of the cuts (laceration repair) proves to be traumatic for the children and the parents. Nasal spray (Intranasal/IN) approaches for procedural pain reduction, such as during dental work, have been demonstrated to make drug administration painless and well tolerated. We are comparing IN...
What is the current status of trial NCT03528512?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2018-09-04. Estimated completion is 2019-02-06.
What interventions are being tested in trial NCT03528512?
The interventions under investigation include: Ketamine (DRUG), Midazolam and fentanyl (DRUG).
Who is sponsoring clinical trial NCT03528512?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.